论文部分内容阅读
稳心颗粒1995年由卫生部批准为三类新药,其药物组成和处方工艺已获国家发明专利。稳心颗粒主要用于治疗气阴两虚、心脉瘀阻之心动悸、脉结代。症见气短乏力,心悸不宁,头晕心烦、胸闷胸痛,脉结代或虚数。目前稳心颗粒国在内外的实验室方面已做过很多研究,本文就稳心颗粒抗心律失常的离子通道作用机制研究进展作一概述。
Wenxin particles approved by the Ministry of Health in 1995 as three types of new drugs, the pharmaceutical composition and prescription technology has won the national invention patents. Wenxin particles are mainly used to treat Qi and Yin Deficiency, heart palpitations stasis heart pulse, pulse generation. Zheng Jian Qi shortness of breath, palpitations restless, dizzy and upset, chest tightness, chest pain, pulse generation or virtual number. At present, many researchers have done a lot of research in the laboratories both inside and outside the country. In this paper, the research progresses on the mechanism of ion channels of Wenxin Granule against arrhythmia are summarized.